CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES >
Fasciola hepatica infection complicated by hepatic tuberculosis: a case report
Received date: 2024-09-26
Revised date: 2024-10-26
Online published: 2025-04-27
Supported by
Key Laboratory of Infectious Diseases Project of Yunnan Provincial Department of Education (YJF [2022] No. 70)
A 58-year-old male farmer living in Binchuan County, Dali, Yunnan Province, was admitted to the First Affiliated Hospital of Dali University on July 20, 2022, with a complaint of “right upper abdominal pain for more than two days”. Routine blood tests showed elevated eosinophils counts (1.7 × 109/L), erythrocyte sedimentation rate (ESR, > 120 mm/h), and blood chemical tests showed an increase in alanine aminotransferase (58 U/L), aspartate aminotransferase (74 U/L), gamma-glutamyltransferase (66 U/L) and alkaline phosphatase concentrations (257 U/L). Enzyme-linked immunosorbent assay (ELISA) measured strongly positive serum IgM and IgG antibodies against Fasciola hepatica, and the T-SPOT. TB test was tested positive. Abdominal plain plus enhanced computed tomography (CT) scans displayed the suspicion of hepatic malignancy with infectious diseases that failed to be excluded. Liver histopathology revealed tunnel-like necrosis and formation of foreign body granulomas, with F. hepatica infection and tuberculosis that cannot be excluded. Acid-fast staining of the left medial lobe liver specimen was positive, and Mycobacterium tuberculosis complex DNA was detected. Metagenomic next-generation sequencing (mNGS) of liver tissues detected 20 M. tuberculosis sequences and 15 F. hepatica sequences. The patient resided in Binchuan County, Dali Prefecture, Yunnan Province, where fascioliasis is prevalent, and had a habit of consuming raw or undercooked vegetables. Fascioliasis hepatica complicated by hepatic tuberculosis was diagnosed based on the patient’s epidemiological history, symptoms and signs, and auxiliary diagnosis results. Following deworming with triclabendazole at a dose of 15 mg/(kg·d) divided into 3 doses per day for 2 days and antitubercular therapy with rifampicin capsules (0.45 g once daily, adjusted for the patient’s weight of 48 kg), isoniazid tablets (0.3 g once daily), ethambutol tablets (0.75 g once daily) and pyrazinamide tablets (1.5 g once daily) for a week, the patient’s abdominal pain improved and was discharged from hospital. At the 3-month follow-up, liver enzymes returned to normal, and at the 6-month follow-up, the case had normal eosinophil counts, postoperative changes in liver segment 4 and strip-like dense shadows in surgical areas on plain abdominal CT scans, without remarkable progression.
HUANG Lihua , WU Jun , LI Zhengjin , LUO Jiao , GU Wei . Fasciola hepatica infection complicated by hepatic tuberculosis: a case report[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2025 , 43(2) : 304 -306 . DOI: 10.12140/j.issn.1000-7423.2025.02.026
| [1] | 李芹翠, 陈凤, 顾伟, 等. 云南省65例片形吸虫病临床特点[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(4): 521-523. |
| Li QC, Chen F, Gu W, et al. Clinical features of 65 cases of fascioliasis in Yunnan Province[J]. Chin J Parasitol Parasit Dis, 2020, 38(4): 521-523. (in Chinese) | |
| [2] | Kale A, Patil PS, Chhanchure U, et al. Hepatic tuberculosis masquerading as malignancy[J]. Hepatol Int, 2022, 16(2): 463-472. |
| [3] | 陈鹏, 唐少珊, 苏梦雪, 等. 肝结核误诊为肝转移癌2例报道并文献复习[J]. 中国医科大学学报, 2022, 51(10): 936-940. |
| Chen P, Tang SS, Su MX, et al. Hepatic tuberculosis misdiagnosed as hepatic metastasis: Two cases report and literature review[J]. J China Med Univ, 2022, 51(10): 936-940. (in Chinese) | |
| [4] | 中华人民共和国国家卫生和计划生育委员会. 片形吸虫病诊断: WS/T 566—2017[S]. 北京: 中国标准出版社, 2017: 1-11. |
| National Health and Family Planning Commission of the People’s Republic of China. Diagnosis of fascioliasis: WS/T 566—2017[S]. Beijing: Standards Press of China, 2017: 1-11. (in Chinese) | |
| [5] | Huang LH, Li FX, Su HY, et al. Emerging human fascioliasis: A retrospective study of epidemiological findings in Dali, Yunnan Province, China (2012-2021)[J]. Med Sci Monit, 2023, 29: e940581. |
| [6] | 陆君君, 焦建明, 李权润, 等. 肝脏巨片形吸虫感染的CT表现及转归[J]. 大理大学学报, 2017, 2(10): 67-69. |
| Lu JJ, Jiao JM, Li QR, et al. CT findings and outcomes of hepatic Fasciola gigantica disease[J]. J Dali Univ, 2017, 2(10): 67-69. (in Chinese) | |
| [7] | 李琴, 杜伟, 张靓, 等. 人体肝脏巨片形吸虫感染影像学表现[J]. 影像诊断与介入放射学, 2014, 23(3): 200-204. |
| Li Q, Du W, Zhang L, et al. Imaging findings of hepatic Fasciola gigantica[J]. Diagn Imag Interv Radiol, 2014, 23(3): 200-204. (in Chinese) | |
| [8] | Chiu CY, Miller SA. Clinical metagenomics[J]. Nat Rev Genet, 2019, 20(6): 341-355. |
| [9] | Guo F, Kang L, Xu MX. A case of pediatric visceral leishmaniasis-related hemophagocytic lymphohistiocytosis diagnosed by mNGS[J]. Int J Infect Dis, 2020, 97: 27-29. |
| [10] | Perlejewski K, Radkowski M, Pawe?czyk A, et al. Enteroviral central nervous system infections in patients with Lyme neuroborreliosis[J]. Ticks Tick Borne Dis, 2023, 14(6): 102253. |
| [11] | Song P, Li X. Diagnostic value of metagenomics next-generation sequencing technology in disseminated strongyloidiasis[J]. World J Clin Cases, 2022, 10(33): 12455-12457. |
| [12] | Wang M, Liu W, Xiong ZM, et al. Case report: “area of focus” atypical trichinellosis and fascioliasis coinfection[J]. Front Med (Lausanne), 2022, 9: 881356. |
| [13] | Zhang YL, Xu H, Liu Y, et al. Case report: Fascioliasis hepatica precisely diagnosed by metagenomic next-generation sequencing and treated with albendazole[J]. Front Med (Lausanne), 2021, 8: 773145. |
| [14] | 张伟娜, 顾伟, 焦建明, 等. 15例片形吸虫病患者临床资料分析[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(2): 207-212. |
| Zhang WN, Gu W, Jiao JM, et al. Analysis of clinical features on 15 cases of fascioliasis[J]. Chin J Parasitol Parasit Dis, 2019, 37(2): 207-212. (in Chinese) | |
| [15] | 肖科, 税雪姣, 赵东霞, 等. 肝脏结核1例并文献复习[J]. 中国感染与化疗杂志, 2019, 19(1): 32-37. |
| Xiao K, Shui XJ, Zhao DX, et al. Hepatic tuberculosis: One case report and literature review[J]. Chin J Infect Chemother, 2019, 19(1): 32-37. (in Chinese) |
/
| 〈 |
|
〉 |